Products

Primary tabs

Export products to Excel

Displaying 91 - 105 of 166
Alternative Name: MZCL Combination IVR
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Target ID/Validation
Development Status: Limited Market Approval
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Alternative Name: Nestorone (NES) + Estradiol (E2) Vaginal Ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Alternative Name: Nestorone (NES) Single Rod Implant
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase II
Alternative Name: Nestorone (NES) Metered Dose Transdermal System® (MDTS®)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Alternative Name: Nestorone (NES) + Estradiol (E2) Transdermal Gel
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Biodegradable Norethindrone (NET) Pellets
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase II
Alternative Name: Lavax Vaginal Suppository
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal, Other
Project Stage: Target ID/Validation
Partner: Lavax
Alternative Name: Nomegestrol acetate (NOMAC) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Partner: Merck
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Partner: Actavis
Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Export to Excel